scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.TRANSPROCEED.2016.02.024 |
P698 | PubMed publication ID | 27110018 |
P50 | author | Gustavo Varela-Fascinetto | Q58396687 |
P2093 | author name string | L Velásquez-Jones | |
S Valverde | |||
M Medeiros | |||
P García-Roca | |||
A C Alvarez-Elías | |||
P2860 | cites work | New equations to estimate GFR in children with CKD | Q24642417 |
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing. | Q35782898 | ||
Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation. | Q36125433 | ||
The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation. | Q38163945 | ||
Kidney transplantation in children | Q38237543 | ||
Use of pharmacogenomics in pediatric renal transplant recipients | Q38367819 | ||
Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients | Q43043698 | ||
Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians | Q45281322 | ||
A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype. | Q46796371 | ||
CYP3A5 polymorphism in Mexican renal transplant recipients and its association with tacrolimus dosing | Q47614121 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 631-634 | |
P577 | publication date | 2016-03-01 | |
P1433 | published in | Transplantation Proceedings | Q7834825 |
P1476 | title | CYP3A5 Genotype and Time to Reach Tacrolimus Therapeutic Levels in Renal Transplant Children | |
P478 | volume | 48 |
Q53702610 | Calcineurin inhibitors and nephrotoxicity in children. |
Q28073025 | Economic Evaluation of Pharmacogenetic Tests in Patients Subjected to Renal Transplantation: A Review of Literature |
Q92863281 | Genome-Wide Association Study of Tacrolimus Pharmacokinetics Identifies Novel Single Nucleotide Polymorphisms in the Convalescence and Stabilization Periods of Post-transplant Liver Function |
Q52594698 | Population Pharmacokinetics of Tacrolimus in Children with Nephrotic Syndrome. |
Search more.